Image may differ
AESKULISA®
Reference:
30-7205US
Designation:
β2-Glyco-A
Intended use:

AESKULISA® ß2-Glyco-A is a solid phase enzyme immunoassay employing native ß2 glycoprotein I highly purified from human plasma for the semiquantitative and qualitative detection of IgA antibodies against ß2 glycoprotein I in human serum. The presence of anti-ß2 glycoprotein I antibodies in conjunction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary and secondary antiphospholipid syndrome.

Method:
ELISA
Conjugate:
IgA
Analysis:
Qualitative
,
Semi-quantitative
Cut Off:
15 U/ml
Measurement range:
0-300 U/ml
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
FDA-cleared
Coated Antigens:
ß2-glycoprotein I
AESKULISA®

30-7205US

β2-Glyco-A

Image may differ
Intended use:

AESKULISA® ß2-Glyco-A is a solid phase enzyme immunoassay employing native ß2 glycoprotein I highly purified from human plasma for the semiquantitative and qualitative detection of IgA antibodies against ß2 glycoprotein I in human serum. The presence of anti-ß2 glycoprotein I antibodies in conjunction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary and secondary antiphospholipid syndrome.

Method:
ELISA
Conjugate:
IgA
Analysis:
Qualitative
,
Semi-quantitative
Cut Off:
15 U/ml
Measurement range:
0-300 U/ml
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
FDA-cleared
Coated Antigens:
ß2-glycoprotein I
Downloads
All related documents and information clearly summarized

Instructions for Use